FindTrial
Sign In

Effect of esketamine in self-controlled intravenous analgesia

Effect of esketamine in self-controlled intravenous analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096348
Enrollment
Unknown
Registered
2025-01-22
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group C:PCIA: Sufentanil + tropisetron
Group D:PCIA: Sufentanil + Esketamine + tropisetron

Sponsors

Sir Run Run Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients receiving postoperative controlled intravenous analgesia; (2) Patients aged 18-85 with complete clinical records; (3) ASA classification I-III.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of allergy to the experimental drug; (2) evidence of anesthesia contraindications; (3) Patients with heart, lung, liver, kidney, blood and other important system diseases; (4) Patients with communication or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Postoperative pain score;—

Secondary

MeasureTime frame
Postoperative sedation score;Number of postoperative analgesic pump compressions;Postoperative neuropsychiatric symptoms;Postoperative sleep;Blood pressure;Heart rate;Oxygen Saturation (SpO2);First time out of bed;First exhaust time;Time of first defecation;Postoperative adverse reaction;Depressive mood score;—

Countries

China

Contacts

Public ContactZheng Longbin

Sir Run Run Hospital Affiliated to Nanjing Medical University

272425852@qq.com+86 180 6175 0597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026